BioWinConnect "Delivering innovative biomarker assays for Immuno-oncology translational research & clinical trials".

24 octobre 2019   Evènement

One of the biggest challenge in cancer patient treatment today is to find accurately which patients will benefit from immunotherapy or combination of therapies. For drug developers, the assessment of immune biomarkers through translational and clinical research studies allow a strong understanding of the tumor micro-environment and support the development of the biomarker strategy.

Please fill in all the fields.

Registration is free for BioWin members. The fee costs 150€ for non-members.

For your registration to be validated, please click on "Envoyer mon inscription à la validation" at the bottom of page 2.

  • Les inscriptions sont clôturées